• FirefoxInstall the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.18%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    104.12 Up 1.06(1.03%) 9:46AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:103.06
    Open:103.43
    Bid:103.65 x 100
    Ask:103.75 x 400
    1y Target Est:119.15
    Beta:0.83
    Earnings Date:Apr 20 - Apr 24 (Est.)
    Day's Range:103.14 - 104.25
    52wk Range:63.50 - 116.83
    Volume:691,223
    Avg Vol (3m):16,321,200
    Market Cap:155.08B
    P/E (ttm):14.17
    EPS (ttm):7.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 1.03%155.08B
    GSKUp 0.27%115.34B
    PFEUp 0.17%212.67B
    RHHBYDown 0.03%N/A

    Key Statistics

    Forward P/E (1 yr):10.02
    P/S (ttm):6.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :9.53
    Quarterly EPS Est (Mar-15) :2.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.75

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback